F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Update

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 22,041 shares, a growth of 115.9% from the June 30th total of 10,208 shares. Based on an average daily volume of 9,029 shares, the short-interest ratio is currently 2.4 days. Approximately 0.8% of the company’s shares are short sold.

F/m Emerald Life Sciences Innovation ETF Stock Down 0.2%

NASDAQ:LFSC traded down $0.10 during trading hours on Tuesday, hitting $45.19. 2,933 shares of the stock were exchanged, compared to its average volume of 4,763. The company’s 50 day moving average is $42.33 and its two-hundred day moving average is $38.29. F/m Emerald Life Sciences Innovation ETF has a twelve month low of $24.22 and a twelve month high of $47.68.

Hedge Funds Weigh In On F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC raised its holdings in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 13.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 45,908 shares of the company’s stock after acquiring an additional 5,312 shares during the period. Hunter Associates Investment Management LLC owned approximately 1.81% of F/m Emerald Life Sciences Innovation ETF worth $1,684,000 at the end of the most recent reporting period.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.